ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma

Aldehyde dehydrogenase 1 family member L1 (ALDH1L1) is downregulated in hepatocellular carcinoma (HCC) tumors, and its decreased expression is associated with the poor prognosis of HCC patients. We, therefore, evaluated the effect of single nucleotide polymorphisms (SNPs) of ALDH1L1, and its mRNA ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Guangzhi, Liao, Xiwen, Han, Chuangye, Liu, Xiaoguang, Yu, Long, Qin, Wei, Lu, Sicong, Su, Hao, Chen, Zhiwei, Liu, Zhengtao, Liang, Yu, Huang, Jianlu, Yu, Tingdong, Yang, Chengkun, Huang, Ketuan, Shang, Liming, Ye, Xinping, Li, Lequn, Qin, Xue, Xiao, Kaiyin, Peng, Minhao, Peng, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549030/
https://www.ncbi.nlm.nih.gov/pubmed/28714006
http://dx.doi.org/10.3892/or.2017.5822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549030/
https://www.ncbi.nlm.nih.gov/pubmed/28714006
http://dx.doi.org/10.3892/or.2017.5822

Ejemplares similares